生物活性 | |||
---|---|---|---|
描述 | Mitiperstat (AZD4831) is a potent inhibitor of myeloperoxidase (MPO) and is particularly valuable in research aimed at the prophylaxis of cardiovascular disorders, including heart failure and coronary artery disease, as outlined in patent US20160152623A1[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.99mL 0.60mL 0.30mL |
14.93mL 2.99mL 1.49mL |
29.87mL 5.97mL 2.99mL |
参考文献 |
---|